US drug regulator rejects emergency use approval for Bharat Biotech’s Covaxin
- 3 years ago
The US Food and Drug Administration on Friday rejected Bharat Biotech’s proposal for emergency use authorisation of its coronavirus, Covaxin. The development comes at a time when many countries do not recognise Covaxin. For more, watch the full video.